All comparisons
LLY vs NVO
Eli Lilly and Company vs Novo Nordisk A/S
Overview
LLYEli Lilly and Company
Score A+Price
$1,146.85
Fair Value
$1,404.87
Upside
+22.5%
Conviction
10/10
NVONovo Nordisk A/S
Score BPrice
$49.61
Fair Value
$78.55
Upside
+58.3%
Conviction
10/10
Valuation
LLY
Bear$1,032.16
Base$1,617.48
Bull$2,774.94
Fair Value$1,404.87
NVO
Bear$44.65
Base$69.68
Bull$76.65
Fair Value$78.55
Quality
LLY
Grade
A
Score
116/100
Classification
Growth
Rating
Score A+
NVO
Grade
A
Score
106/100
Classification
Compounder
Rating
Score B
Company Info
| LLY | NVO | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Growth | Compounder |
Verdict
LLY has better risk/reward
NVO: Higher upside potentialLLY: Better quality grade